These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15274674)

  • 41. The effect of double dose of omeprazole on the course of angina pectoris and treadmill stress test in patients with coronary artery disease--a randomised, double-blind, placebo controlled, crossover trial.
    Budzyński J; Kłopocka M; Pulkowski G; Suppan K; Fabisiak J; Majer M; Swiatkowski M
    Int J Cardiol; 2008 Jul; 127(2):233-9. PubMed ID: 17689732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial.
    Ott EA; Mazzoleni LE; Edelweiss MI; Sander GB; Wortmann AC; Theil AL; Somm G; Cartell A; Rivero LF; Uchôa DM; Francesconi CF; Prolla JC
    Aliment Pharmacol Ther; 2005 May; 21(10):1231-9. PubMed ID: 15882244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use.
    Ford AC; Forman D; Nathan J; Crocombe WD; Axon AT; Moayyedi P
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1267-75. PubMed ID: 17944741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treat the patients' main dyspepsia complaint, not the ROME criteria.
    Chiba N
    Am J Gastroenterol; 2004 Jun; 99(6):1059-62. PubMed ID: 15180725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A placebo-controlled trial of an oral capsaicin load in patients with functional dyspepsia.
    Führer M; Vogelsang H; Hammer J
    Neurogastroenterol Motil; 2011 Oct; 23(10):918-e397. PubMed ID: 21883698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of upper endoscopy on satisfaction in patients with previously uninvestigated dyspepsia.
    Rabeneck L; Wristers K; Souchek J; Ambriz E
    Gastrointest Endosc; 2003 Mar; 57(3):295-9. PubMed ID: 12612505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of a complex homeopathic medication (Sinfrontal) in patients with acute maxillary sinusitis: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Zabolotnyi DI; Kneis KC; Richardson A; Rettenberger R; Heger M; Kaszkin-Bettag M; Heger PW
    Explore (NY); 2007; 3(2):98-109. PubMed ID: 17362845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
    Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis.
    Lundell L; Miettinen P; Myrvold HE; Hatlebakk JG; Wallin L; Malm A; Sutherland I; Walan A;
    Br J Surg; 2007 Feb; 94(2):198-203. PubMed ID: 17256807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of pirenzepine in the treatment of non-ulcer dyspepsia. A double-blind study.
    Hradsky M; Wikander M
    Scand J Gastroenterol Suppl; 1982; 72():251-4. PubMed ID: 6753120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study.
    Meineche-Schmidt V; Talley NJ; Pap A; Kordecki H; Schmid V; Ohlsson L; Wahlqvist P; Wiklund I; Bolling-Sternevald E
    Scand J Gastroenterol; 1999 Jun; 34(6):566-74. PubMed ID: 10440605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies.
    Talley NJ; Lauritsen K
    Gut; 2002 May; 50 Suppl 4(Suppl 4):iv36-41. PubMed ID: 11953346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia; a randomized, double-blind placebo-controlled crossover study.
    Holtmann G; Kutscher SU; Haag S; Langkafel M; Heuft G; Neufang-Hueber J; Goebell H; Senf W; Talley NJ
    Dig Dis Sci; 2004 Apr; 49(4):672-9. PubMed ID: 15185877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health.
    Rabeneck L; Cook KF; Wristers K; Souchek J; Menke T; Wray NP
    J Clin Epidemiol; 2001 Aug; 54(8):755-65. PubMed ID: 11470383
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The symptomatic effect of 1-day treatment periods with cimetidine in dyspepsia. Combined results from randomized, controlled, single-subject trials.
    Johannessen T; Kristensen P; Petersen H; Fosstvedt D; Løge I; Kleveland PM; Dybdahl J
    Scand J Gastroenterol; 1991 Sep; 26(9):974-80. PubMed ID: 1947791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effectiveness of Ultop 10 mg using at treatment of functional (nonulcer) dyspepsia syndrome].
    Burkov SG; Arutiunov AT; Okoemov MN; Anokhina LN; Egorova NV; Makukh EA; Chugunnikova LI
    Eksp Klin Gastroenterol; 2009; (6):122-6. PubMed ID: 20201294
    [No Abstract]   [Full Text] [Related]  

  • 59. Classification of dyspepsia. Identification of independent symptom components in 7270 consecutive, unselected dyspepsia patients from general practice.
    Meineche-Schmidt V; Christensen E
    Scand J Gastroenterol; 1998 Dec; 33(12):1262-72. PubMed ID: 9930389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non ulcer dyspepsia.
    Junghard O; Lauritsen K; Talley NJ; Wiklund IK
    Eur J Surg Suppl; 1998; (583):106-11. PubMed ID: 10027684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.